ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2017

Abstract Number: 721

Improving the Quality of Care in Systemic Lupus Erythematosis (SLE) through Time-Structured, Information Technology-Enhanced, Quality Improvement Indicator-Driven Patient Management

Frank Migliore1, Robert Quinet2, William E. Davis3, Daniel Wray4, Timothy Hilbun5 and Magdelena Budziakowska1, 1Ochsner Clinic Foundation, New Orleans, LA, 2Rheumatology, Ochsner Medical Center, New Orleans, LA, 3University of Queensland School of Medicine, Brisbane, Australia, 4Twine Clinical Consulting LLC, Park City, UT, 5IS ANALYTICS NOM, Ochsner Medical Center, New Orleans, LA

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2017

Date of first publication: September 18, 2017

Keywords: Lupus and quality improvement

Session Information

Date: Sunday, November 5, 2017

Title: Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster I: Biomarkers and Outcomes

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Gaps exist in SLE patient care in monitoring and management of comorbidities, treatment related toxicities, and disease activity, suggesting a lack of well-defined systems of care in SLE. Our hypothesis was that a more time structured, IT enhanced, and QI indicator-driven approach to SLE management would translate to more frequent, comprehensive, and guideline adherent interactions with the lupus patient (“tight” management) that would lead to improved outcomes.

Methods:

To prompt “tight” management of SLE patients at Ochsner main campus (687 patients – 2014 baseline; 644 patients – 2015 interventional; 581 patients – 2016 post-interventional), the following interventions were implemented:

• Lupus Management Module: SLE specific dashboard embedded into Epic EHR. Dashboard incorporates automated SLE management specific reminders, alerts (and facilitates ordering appropriate testing/management), test result tracking, and customized assessments (SELENA-SLEDAI, SLICC- SDI). SLICC-DI assessment is prompted 1x annually. SLEDAI assessment prompted every office visit. The occurrence of flare is prompted tabulated and based on change in SELENA- SLEDAI assessment. Clinicians have the ability to override or confirm the tabulated occurrence of flare. Also, clinicians could manually designate the occurrence of flare independently of the automated tracking system.

• Patient Campaigning: Identification of patients due for SLE specific testing or management activities. Of primary importance were to prompt an office visit at least 1x/6 months and prompt pre office visit lab testing to enable completion of the SELENA- SLEDAI tabulation at the point of care, thereby enabling and facilitating fully informed management decision making at the point of care.

Results:

These interventions prompted improvement in rate of SELENA-SLEDAI application 1x/6 months (26.35% – 2014 baseline period, 43.79% – 2015 interventional period, 39.93% – 2016 post-interventional period; p < 0.0001), rate of SLICC-SDI application 1x/12 months (22.83% – 2015 interventional period, 34.25% – 2016 post-interventional period; p < 0.0001), rate of performance of ALL appropriate labs 1x/6 months (28.38% – 2014 baseline period, 44.57% – 2015 interventional period, 43.37% – 2016 post-interventional period; p < 0.0001), rate of cardiovascular assessment 1x/12 months (35.95% – 2014 baseline period, 51.71% – 2015 interventional period, 46.30% – 2016 post-interventional period; p < 0.0001), rate of influenza vaccination 1x/12 months (18.78% – 2014 baseline period, 29.50% – 2015 interventional period, 37.18% – 2016 post-interventional period; p < 0.0001), rate of lupus flare (16.30% – 2015 interventional period, 12.05% – 2016 post-interventional period; p = 0.0338), and rate of hospitalization (8.59% – 2014 baseline period, 6.68% – 2015 interventional period, 5.68% – 2016 post-interventional period; p = 0.0466).

Conclusion:

Time structured, IT enhanced, and QI indicator driven interventional modalities prompted more frequent, more comprehensive, guideline adherent point of care interaction with SLE patients. “Tighter” management resulted in the improved outcomes of both rate of lupus flare and rate of hospitalization in SLE patients.


Disclosure: F. Migliore, None; R. Quinet, None; W. E. Davis, None; D. Wray, None; T. Hilbun, None; M. Budziakowska, None.

To cite this abstract in AMA style:

Migliore F, Quinet R, Davis WE, Wray D, Hilbun T, Budziakowska M. Improving the Quality of Care in Systemic Lupus Erythematosis (SLE) through Time-Structured, Information Technology-Enhanced, Quality Improvement Indicator-Driven Patient Management [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/improving-the-quality-of-care-in-systemic-lupus-erythematosis-sle-through-time-structured-information-technology-enhanced-quality-improvement-indicator-driven-patient-management/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-the-quality-of-care-in-systemic-lupus-erythematosis-sle-through-time-structured-information-technology-enhanced-quality-improvement-indicator-driven-patient-management/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology